Biomedcode presents an abstract entitled “Characterization Of Novel Humanized Il-17 Preclinical Platforms For The Efficacy Evaluation Of Anti-Human Il17 Therapeutics” in the 39thEuropean Workshop for Rheumatology Research that takes place February 28-March 2 in Lyon France.